Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-27

Clinical Trial Update: Tranexamic Acid Reduce Blood Loss in Meningioma Resection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating tranexamic acid to reduce blood loss during meningioma resection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Chiang Mai University | Conditions: Meningioma | Phase 4 | Status: UNKNOWN